We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+3.26%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.33B
AUM Growth
+$66.7M
Cap. Flow
+$10.5M
Cap. Flow %
0.45%
Top 10 Hldgs %
23.1%
Holding
480
New
25
Increased
142
Reduced
163
Closed
10

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$2.72M
2
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$1.58M
3
PEP icon
PepsiCo
PEP
+$1.46M
4
CELG
Celgene Corp
CELG
+$1.2M
5
TDC icon
Teradata
TDC
+$1.09M

Sector Composition

Rank Sector Weight
1 Healthcare 17.01%
2 Technology 11.79%
3 Industrials 11.62%
4 Financials 11.2%
5 Consumer Staples 10.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGN
26
DELISTED
Allergan Inc
AGN
$23.2M 1%
109,153
-3,543
-3% -$705K
GILD icon
27
Gilead Sciences
GILD
$161B
$23.1M 0.99%
245,326
-943
-0.4% -$97.5K
KRFT
28
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$22.2M 0.95%
355,033
-1,957
-0.5% -$115K
VZ icon
29
Verizon
VZ
$194B
$20.9M 0.9%
446,289
+9,275
+2% +$454K
EMC
30
DELISTED
EMC CORPORATION
EMC
$20.6M 0.89%
693,704
-18,331
-3% -$534K
HON icon
31
Honeywell
HON
$77.1B
$20.6M 0.88%
229,138
-1,601
-0.7% -$138K
DD
32
DELISTED
Du Pont De Nemours E I
DD
$19.6M 0.84%
279,420
-57
-0% -$3.81K
ABT icon
33
Abbott
ABT
$180B
$19.5M 0.84%
433,737
+9,417
+2% +$410K
ECL icon
34
Ecolab
ECL
$75.6B
$19.3M 0.83%
184,422
+295
+0.2% +$32.3K
OXY icon
35
Occidental Petroleum
OXY
$57B
$19.2M 0.82%
238,449
-4,058
-2% -$337K
MET icon
36
MetLife
MET
$61B
$19.1M 0.82%
396,761
+614
+0.2% +$29.2K
MMM icon
37
3M
MMM
$89B
$19M 0.81%
138,097
-1,394
-1% -$179K
BRK.B icon
38
Berkshire Hathaway Class B
BRK.B
$1.07T
$18.5M 0.79%
123,221
-10
-0% -$1.44K
NGG icon
39
National Grid
NGG
$82.7B
$17.7M 0.76%
259,764
-425
-0.2% -$29.5K
MRK icon
40
Merck
MRK
$324B
$17.6M 0.75%
324,224
+3,885
+1% +$216K
ABBV icon
41
AbbVie
ABBV
$458B
$16.8M 0.72%
256,208
-3,099
-1% -$195K
NOV icon
42
NOV
NOV
$7.45B
$16.5M 0.71%
251,941
-5,327
-2% -$371K
ASML icon
43
ASML
ASML
$675B
$16.3M 0.7%
151,550
+9,695
+7% +$983K
NKE icon
44
Nike
NKE
$61.9B
$15.9M 0.68%
331,468
+994
+0.3% +$46.6K
CAT icon
45
Caterpillar
CAT
$409B
$15.5M 0.67%
169,459
-11,045
-6% -$1.08M
TGT icon
46
Target
TGT
$62.1B
$14.7M 0.63%
193,157
-2,179
-1% -$147K
DHR icon
47
Danaher
DHR
$135B
$14.5M 0.62%
251,246
+2,787
+1% +$151K
WFC icon
48
Wells Fargo
WFC
$261B
$14.3M 0.61%
260,851
-2,117
-0.8% -$112K
UN
49
DELISTED
Unilever NV New York Registry Shares
UN
$14.2M 0.61%
364,960
+6,390
+2% +$250K
PFE icon
50
Pfizer
PFE
$140B
$14.2M 0.61%
479,108
-1,246
-0.3% -$35.7K

Similar funds

Gofen & Glossberg's Q4 2014 Portfolio in Review

As of Q4 2014, Gofen & Glossberg held 480 positions worth $2.33B, up 2.9% from $2.26B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Gofen & Glossberg's Q4 2014 filing shows 25 new, 142 increased, 163 reduced and 10 closed positions. Its largest new stake was Vanguard FTSE Developed Markets ETF: 15,650 shares worth $593K. The largest sale was IBM, an estimated $2.72M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

  • Gofen & Glossberg's largest Q4 2014 buy was Vanguard FTSE Developed Markets ETF: 15,650 shares worth $593K.
  • Gofen & Glossberg added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $9.11M increase.
  • Gofen & Glossberg's biggest Q4 2014 reduction was IBM, cutting an estimated $2.72M.
  • Gofen & Glossberg fully exited KINDER MORGAN ENER PNTRS L.P. in Q4 2014, selling an estimated $418K.
  • Gofen & Glossberg's ten largest holdings make up 23% of its $2.33B portfolio in Q4 2014.
  • Gofen & Glossberg opened 25 new positions and closed 10 in Q4 2014.
  • Gofen & Glossberg's portfolio value rose 2.9% quarter-over-quarter to $2.33B.

Based on Gofen & Glossberg's 13F filing for Q4 2014, filed 9 Feb 2015.